Related Experiment Video
Updated: Aug 8, 2026

09:46
Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
Primary immune-mediated thrombocytopenia in a cat
S Tasker1, A J Mackin, M J Day
1Department of Veterinary Clinical Studies, Royal (Dick) School of Veterinary Studies, University of Edinburgh.
The Journal of Small Animal Practice
|April 14, 1999
Summary
A Somali cat with chronic hematuria had immune-mediated thrombocytopenia. Treatment with dexamethasone successfully resolved the condition after other immunosuppressants failed.
Area of Science:
- Veterinary Internal Medicine
- Immunology
- Hematology
Background:
- Immune-mediated thrombocytopenia (ITP) is a rare but serious condition in cats.
- Diagnosis involves identifying anti-platelet antibodies and ruling out secondary causes.
- Chronic intermittent haematuria can be a presenting sign.
Observation:
- A young female Somali cat presented with chronic intermittent haematuria and petechiae.
- Severe thrombocytopenia and megakaryocyte hyperplasia were identified.
- Direct marrow immunohistochemistry detected anti-megakaryocyte autoantibody (Immunoglobulin G).
Findings:
- A diagnosis of primary immune-mediated thrombocytopenia was made after excluding secondary causes.
- Initial immunosuppressive therapy with prednisolone, azathioprine, and vincristine was ineffective.
- Thrombocytopenia resolved following a switch to dexamethasone therapy.
Implications:
- Dexamethasone may be a more effective treatment for feline primary immune-mediated thrombocytopenia than other immunosuppressants.
- This case highlights the importance of thorough investigation for ITP in cats presenting with haematuria.
- Further research into feline ITP treatment protocols is warranted.

